Search Results - "Leon, Kelly E."
-
1
ATM inhibition drives metabolic adaptation via induction of macropinocytosis
Published in The Journal of cell biology (02-01-2023)“…Macropinocytosis is a nonspecific endocytic process that may enhance cancer cell survival under nutrient-poor conditions. Ataxia-Telangiectasia mutated (ATM)…”
Get full text
Journal Article -
2
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Published in Cell reports (Cambridge) (20-08-2019)“…Reprogrammed metabolism and cell cycle dysregulation are two cancer hallmarks. p16 is a cell cycle inhibitor and tumor suppressor that is upregulated during…”
Get full text
Journal Article -
3
Loss of p16: A Bouncer of the Immunological Surveillance?
Published in Life (Basel, Switzerland) (02-04-2021)“…p16 (hereafter called p16) is an important tumor suppressor protein frequently suppressed in human cancer and highly upregulated in many types of senescence…”
Get full text
Journal Article -
4
GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment
Published in Redox biology (01-07-2019)“…Ovarian cancer remains the most lethal gynecologic malignancy, and is primarily diagnosed at late stage when considerable metastasis has occurred in the…”
Get full text
Journal Article -
5
Jumonji C Demethylases in Cellular Senescence
Published in Genes (09-01-2019)“…Senescence is a stable cell cycle arrest that is either tumor suppressive or tumor promoting depending on context. Epigenetic changes such as histone…”
Get full text
Journal Article -
6
The ESCRT-III Protein Chmp1 Regulates Lipid Storage in the Drosophila Fat Body
Published in Medical sciences (Basel) (26-12-2022)“…Defects in how excess nutrients are stored as triglycerides can result in several diseases including obesity, heart disease, and diabetes. Understanding the…”
Get full text
Journal Article -
7
ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells
Published in Heliyon (01-09-2020)“…While therapies targeting deficiencies in the homologous recombination (HR) pathway are emerging as the standard treatment for high grade serous ovarian cancer…”
Get full text
Journal Article -
8
Suppression of p16 alleviates the senescence-associated secretory phenotype
Published in Aging (Albany, NY.) (06-02-2021)“…Oncogene-induced senescence (OIS) is characterized by increased expression of the cell cycle inhibitor p16, leading to a hallmark cell cycle arrest…”
Get full text
Journal Article -
9
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
Published in The Journal of cell biology (02-08-2021)“…Oncogene-induced senescence (OIS) is a stable cell cycle arrest that occurs in normal cells upon oncogene activation. Cells undergoing OIS express a wide…”
Get full text
Journal Article -
10
Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Published in Molecular cancer research (01-08-2019)“…Epithelial ovarian cancer (EOC) is the deadliest gynecologic cancer. High-grade serous carcinoma (HGSC) is the most frequently diagnosed and lethal…”
Get full text
Journal Article -
11
The regulation of triglyceride storage by ornithine decarboxylase (Odc1) in Drosophila
Published in Biochemical and biophysical research communications (05-03-2020)“…Polyamines are low molecular weight, organic cations that play a critical role in many major cellular processes including cell cycle regulation and apoptosis,…”
Get full text
Journal Article -
12
Suppression of p16 alleviates the senescence-associated secretory phenotype
Published in Aging (Albany, NY.) (15-02-2021)Get full text
Journal Article -
13
Abstract A38: ATM inhibitor synergizes with glycolysis inhibition in ovarian cancer cells
Published in Clinical cancer research (01-07-2020)“…Epithelial ovarian cancer (EOC) is the deadliest gynecologic malignancy in the USA. While therapies such as inhibitors against poly (ADP-Ribose) polymerase…”
Get full text
Journal Article -
14
Abstract A35: Targeting the IDH1-mediated metabolic-epigenetic axis in cyclin E-high ovarian cancer
Published in Clinical cancer research (01-07-2020)“…Cyclin E is an oncogene that is overexpressed in approximately 20% of high-grade serous ovarian carcinomas (HGSOC) and is associated with worse survival and…”
Get full text
Journal Article -
15
Abstract 1378: Targeting the metabolic-epigenetic axis to sensitize HR-proficient ovarian cancer to PARP inhibitors
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Overexpression of the oncogene cyclin E1 is considered one of the initiating factors in fallopian tube transformation and ovarian tumorigenesis. Patients with…”
Get full text
Journal Article -
16
The ESCRT-III Protein IChmp1/I Regulates Lipid Storage in the IDrosophila/I Fat Body
Published in Medical sciences (Basel) (01-12-2022)“…Defects in how excess nutrients are stored as triglycerides can result in several diseases including obesity, heart disease, and diabetes. Understanding the…”
Get full text
Journal Article -
17
Targeting IDH1 as a pro-senescent therapy in high-grade serous ovarian cancer
Published in Molecular cancer research (20-05-2019)“…Epithelial ovarian cancer (EOC) is the deadliest gynecological cancer. High-grade serous carcinoma (HGSC) is the most frequently diagnosed and lethal…”
Get full text
Journal Article